<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<page>
<body bgcolor="#FFFFFF"> <p align="center"><font size="2" face="serif"><b>As filed with the Securities and Exchange Commission on May 3, 2006</b></font></p>
<p align="right"><font size="2" face="serif"><b>Registration No. 333-_________</b></font></p>
<p align="center"><font size="2" face="serif"><b>SECURITIES AND EXCHANGE COMMISSION<br>Washington, D.C.  20549</b></font></p>
<p align="center"><font size="2" face="serif"><b>____________________</b></font></p>
<p align="center"><font size="2" face="serif"><b>FORM S-8<br>REGISTRATION STATEMENT UNDER THE<br>SECURITIES ACT OF 1933</b></font></p>
<p align="center"><font size="2" face="serif"><b>____________________</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td colspan="3" align="center"><font size="2" face="serif"><b><u>eResearchTechnology, Inc.</u></b></font></td>
</tr>
<tr valign="top">
<td colspan="3" align="center"><font size="2" face="serif"><b><font face="serif" size="1"></font>
<font face="serif" size="1">(Exact Name of Registrant as Specified in its Charter)</font></b></font></td>
</tr>
<tr valign="top">
  <td width="64%" align="center">&nbsp;</td>
  <td width="36%" colspan="2" align="left">&nbsp;</td>
</tr>
<tr valign="top">
  <td align="center">&nbsp;</td>
  <td colspan="2" align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>Delaware</u></b></font></td>
<td colspan="2" align="left"><div align="center"><font size="2" face="serif"><b><u>22-3264604<br>
</u></b></font></div></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><font face="serif" size="1">(State or other jurisdiction of incorporation or organization)</font></b></font></td>
<td colspan="2" align="left"><div align="center"><font size="1" face="serif"><b>(I.R.S. Employer Identification No.)</b></font></div></td>
</tr>
<tr valign="top">
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td align="center"><font size="2" face="serif"><b>30 South 17<sup>th</sup> Street<u><br>
  Philadelphia, Pennsylvania<br></u><font face="serif" size="1">(Address of Principal Executive Offices)</font></b></font></td>
<td colspan="2" align="left" valign="bottom"><div align="center"><font size="2" face="serif"><u><b>19103</b></u></font><br>
<font size="1" face="serif"><b>(Zip Code)</b></font></div></td>
</tr>
<tr valign="top">
<td colspan="3" align="center"><font size="2" face="serif"><font face="serif" size="1"></font></font></td>
</tr>
<tr valign="top">
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td colspan="2" align="center"><font size="2" face="serif"><font face="serif" size="1"><br></font></font></td>
</tr>
</table>
<p align="center"><font size="2" face="serif"><b>eResearchTechnology, Inc.<br>
</b></font><font size="2" face="serif"><b><u>2003
Stock Option Plan&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>
</u></b></font><b><font face="serif" size="1">(Full title of plan)</font></b></p>
<p align="center"><font size="2" face="serif"><b>______________________<br>
</b></font><font size="2" face="serif"><b>Joel Morganroth, M.D.<br>
</b></font><font size="2" face="serif"><b>Chairman of the Board and<br>
</b></font><font size="2" face="serif"><b>Chief Scientific Officer<br>
eResearchTechnology, Inc.<br>
</b></font><font size="2" face="serif"><b>30 South 17<sup>th</sup> Street<br>
Philadelphia, Pennsylvania  19103<br>
</b></font><font size="2" face="serif"><b><u>(215)
972-0420&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>
</u></b></font><b><font face="serif" size="1">(Name, address and telephone number of agent for service)</font></b></p>
<p align="center"><font size="2" face="serif"><b>____________________<br>
</b></font><font size="2" face="serif"><b>Copy to:<br>
</b></font><font size="2" face="serif"><b>Thomas G. Spencer, Esquire<br>
</b></font><font size="2" face="serif"><b>Duane Morris LLP<br>
</b></font><font size="2" face="serif"><b>30 South 17<sup>th</sup> Street<br>
</b></font><font size="2" face="serif"><b>Philadelphia, Pennsylvania  19103-7396</b></font></p>
<p align="center"><font size="2" face="serif"><b>CALCULATION OF REGISTRATION FEE</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#FFFFFF">
  <td colspan="14" align="left"><hr size="2" noshade></td>
  </tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><div align="center"><font size="2" face="serif"><b><br>
  Title of securities<br>
  to be registered</b></font></div></td>
<td align="left" width="2%">&nbsp;</td>
<td width="1%" align="right">&nbsp;</td>
<td width="17%" align="center"><font size="2" face="serif"><b><br>Amount to be<br>Registered(1)</b></font></td>
<td width="2%" align="left">&nbsp;</td>
<td width="1%" align="right">&nbsp;</td>
<td width="17%" align="center"><font size="2" face="serif"><b>Proposed<br>maximum offering<br>price per share(2)</b></font></td>
<td width="2%" align="left">&nbsp;</td>
<td width="1%" align="right">&nbsp;</td>
<td width="17%" align="center"><font size="2" face="serif"><b>Proposed<br>maximum aggregate<br>offering price(2)</b></font></td>
<td width="2%" align="left">&nbsp;</td>
<td width="1%" align="right">&nbsp;</td>
<td width="17%" align="center"><font size="2" face="serif"><b><br>Amount of<br>registration fee</b></font></td>
<td width="2%" align="left">&nbsp;</td> </tr>
<tr valign="top" bgcolor="#ffffff">
  <td colspan="14" align="left"><hr size="1" noshade></td>
  </tr>
<tr valign="top" bgcolor="#ffffff">
<td align="left"><div align="center"><font size="2" face="serif"><b>Common Stock,<br>
  par value $.01</b></font></div></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="center"><font size="2" face="serif"><b><br>3,500,000 shares</b></font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="right"><div align="center"><font size="2" face="serif"><b><br>
  $11.095</b></font></div></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="right"><div align="center"><font size="2" face="serif"><b><br>
  $38,832,500</b></font></div></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="right"><div align="center"><font size="2" face="serif"><b><br>
  $4,156</b></font></div></td>
<td align="left">&nbsp;</td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td colspan="2"><hr size="2" noshade></td>
  </tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td>&nbsp;</td>
</tr>
<tr valign="top">
<td width="3%">
<font size="2" face="serif"><b>(1)</b></font></td>
<td>
<font size="2" face="serif"><b>This registration statement registers an additional 3,500,000 shares to be offered and sold under the eResearchTechnology, Inc. 2003 Stock Option Plan (the &#8220;Plan&#8221;).  This registration statement also registers such additional shares as may be required to be issued under the Plan in the event of any future stock dividend, reverse stock split, split-up, reclassification and/or other similar event.</b></font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td>&nbsp;</td>
  <td>&nbsp;</td>
</tr>
<tr valign="top">
<td width="3%">
<font size="2" face="serif"><b>(2)</b></font></td>
<td>
<font size="2" face="serif"><b>Pursuant to paragraph (h) of Rule 457, the proposed maximum offering price per share and the proposed maximum aggregate offering price have been computed on the basis of $11.095 per share, the average of the high and low sales prices of the Common Stock of the Company on the Nasdaq National Market System on May 1, 2006, which is a day on which the Common Stock traded that is within five business days prior to the date of filing.</b></font></td>
</tr>
</table>
<p align="center"><font face="serif" size="2"></font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p><a href="#contents"><font size="2">Back to Contents</font></a></p>
<p align="center"><font size="2" face="serif"><b>Introductory statement pursuant
to general instruction E to form s-8</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares being registered hereunder constitute an additional 3,500,000 shares of Common Stock of eResearchTechnology, Inc. (the &#8220;Company&#8221;) for issuance under the Company&#8217;s 2003 Stock Option Plan (the &#8220;Plan&#8221;).  On July 23, 2003, the Company registered 1,700,000 shares of Common Stock for offer and sale under the Plan under the Securities Act of 1933 on Registration Statement No. 333-107272 on Form S-8, which registration statement also registered additional shares of Common Stock issuable under the Plan in the event of any future stock dividend, reverse stock split, split-up, declassification and/or other similar event, such that, as a result of stock dividends subsequently declared and
paid by the Company, such registration statement registered a total of 3,818,625 shares as of the date hereof.  Pursuant to General Instruction E to Form S-8, with respect to the registration of additional securities hereunder for issuance under the Plan, the contents of the Company&#8217;s Registration Statement No. 333-107272 are incorporated herein by reference.  </font></p>
<p align="center"><font size="2" face="serif"><b>PART II</b></font></p>
<p align="center"><font size="2" face="serif"><b>INFORMATION REQUIRED IN REGISTRATION STATEMENT</b></font></p>
<p align="left"><font size="2" face="serif"><b>Item 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporation of Documents by Reference.</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following material is incorporated herein by reference:</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"></td>
<td>
<font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2005 as filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on March 10, 2006.</font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td></td>
  <td>&nbsp;</td>
</tr>
<tr valign="top">
<td width="3%"></td>
<td>
<font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#8217;s Current Reports on Form 8-K as filed with the Commission on January 24, 2006, February 8, 2006 and April 26, 2006.</font></td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td></td>
  <td>&nbsp;</td>
</tr>
<tr valign="top">
<td width="3%"></td>
<td>
<font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The description of the Company&#8217;s Common Stock set forth in the Company&#8217;s Registration Statement on Form S-1 filed with the Commission, File No. 333-17001, declared effective by the Commission on February 3, 1997.</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All reports or other documents filed pursuant to Sections&nbsp;13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 subsequent to the date of this Registration Statement, in each case filed by the Company prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such reports and documents.  Any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for the purposes of this Registration
Statement to the extent that a statement contained herein or in any other subsequently filed document, which also is or is deemed to be incorporated herein by reference, modifies or supersedes such statement.  Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</font></p>
<p align="center"><font face="serif" size="2">1</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p><a href="#contents"><font size="2">Back to Contents</font></a></p>
<p align="left"><font size="2" face="serif"><b>Item 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#ffffff">
<td align="left"><font size="2" face="serif">4</font></td>
<td width="91%" align="left"><font size="2" face="serif">eResearchTechnology, Inc. 2003 Stock Option Plan (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Form 10-Q Report for the Fiscal Quarter Ended June 30, 2003, as filed on August 7, 2003).</font></td>
<td width="2%" align="left">&nbsp;</td> </tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><font size="2" face="serif">5</font></td>
<td align="left"><font size="2" face="serif">Opinion of Duane Morris LLP.</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="left"><font size="2" face="serif">23.1</font></td>
<td align="left"><font size="2" face="serif">Consent of Duane Morris LLP (included in its opinion filed as Exhibit&nbsp;5).</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><font size="2" face="serif">23.2</font></td>
<td align="left"><font size="2" face="serif">Consent of KPMG LLP.</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="left"><font size="2" face="serif">24</font></td>
<td align="left"><font size="2" face="serif">Power of Attorney (included on the signature pages hereto).</font></td>
<td align="left">&nbsp;</td>
</tr>
</table>
<p align="center"><font face="serif" size="2">2</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p><a href="#contents"><font size="2">Back to Contents</font></a></p>
<p align="center"><font size="2" face="serif"><b>SIGNATURES</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&nbsp;S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Philadelphia, Pennsylvania on May 3, 2006.</font></p>
<table width="100%" border="0" align="center" cellpadding="0" cellspacing="0">
<tr valign="top">
<td align="left">&nbsp;</td>
<td colspan="2" align="left"><font size="2" face="serif">eResearchTechnology, Inc.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
<td width="5%">&nbsp;</td>
<td width="35%">&nbsp;</td> </tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">By:</font></td>
<td align="left"><font size="2" face="serif">/s/ Joseph A. Esposito&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td>
</tr>
<tr valign="top">
  <td></td>
<td></td>
<td><hr noshade size="1"></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">Joseph A. Esposito</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">President and Chief Executive Officer</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
</table>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Know all men by these presents, that each person whose signature appears below constitutes and appoints Joel Morganroth, M.D. and Anna Marie Pagliaccetti, and each of them, as such person&#8217;s true and lawful attorneys-in-fact and agents, with full power of substitution, for such person, and in such person&#8217;s name, place and stead, in any and all capacities to sign any or all amendments or post-effective amendments to this Registration Statement, and to file same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof.</font></p>
<p align="center"><font size="2" face="serif">3</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p><a href="#contents"><font size="2">Back to Contents</font></a></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top"> <td align="left"><font size="2" face="serif"><u>Signature</u></font></td>
<td align="left"><font size="2" face="serif"><u>Title</u></font></td>
<td width="21%" align="left"><font size="2" face="serif"><u>Date</u></font></td> </tr>
<tr valign="top">
<td width="44%">&nbsp;</td>
<td width="35%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u>/s/ Joseph A. Esposito</u></font><br>
  <font size="2" face="serif">Joseph A. Esposito</font></td>
<td align="left"><font size="2" face="serif">President, Chief Executive<br>
Officer and Director (Principal executive officer)<br>
</font></td>
<td align="left"><font size="2" face="serif">May 3, 2006<br>
</font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u><br>/s/ Joel Morganroth</u></font><br><font size="2" face="serif">Joel Morganroth, M.D.</font></td>
<td align="left"><font size="2" face="serif"><br>Chairman of the Board and Chief Scientific Officer</font></td>
<td align="left"><font size="2" face="serif"><br>May 3, 2006</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u>/s/ Bruce Johnson</u></font><br><font size="2" face="serif">Bruce Johnson</font></td>
<td align="left"><font size="2" face="serif">Executive Vice President and Chief
    Financial Officer <br>
  (Principal financial and accounting officer)</font></td>
<td align="left"><font size="2" face="serif">May 3, 2006<br>
</font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u><br>/s/ Sheldon M. Bonovitz</u></font><br><font size="2" face="serif">Sheldon M. Bonovitz</font></td>
<td align="left"><font size="2" face="serif"><br>Director</font></td>
<td align="left"><font size="2" face="serif"><br>May 3, 2006</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u>/s/ David D. Gathman</u></font><br><font size="2" face="serif">David D. Gathman</font></td>
<td align="left"><font size="2" face="serif">Director<br>
</font></td>
<td align="left"><font size="2" face="serif">May 3, 2006<br>
</font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u><br>/s/ Gerald A. Faich</u></font><br><font size="2" face="serif">Gerald A. Faich, M.D., M.P.H.</font></td>
<td align="left"><font size="2" face="serif"><br>Director</font></td>
<td align="left"><font size="2" face="serif"><br>May 3, 2006</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u>/s/ Elam M. Hitchner</u></font><br><font size="2" face="serif">Elam M. Hitchner</font></td>
<td align="left"><font size="2" face="serif">Director<br>
</font></td>
<td align="left"><font size="2" face="serif">May 3, 2006<br>
</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u>/s/ John H. Park</u></font><br><font size="2" face="serif">John H. Park</font></td>
<td align="left"><font size="2" face="serif">Director<br>
</font></td>
<td align="left"><font size="2" face="serif">May 3, 2006<br>
</font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u><br>/s/ Stephen S. Phillips</u></font><br><font size="2" face="serif">Stephen S. Phillips</font></td>
<td align="left"><font size="2" face="serif"><br>Director</font></td>
<td align="left"><font size="2" face="serif"><br>May 3, 2006</font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif"><u><br>/s/ Stephen M. Scheppmann</u></font><br><font size="2" face="serif">Stephen M. Scheppmann</font></td>
<td align="left"><font size="2" face="serif"><br>Director</font></td>
<td align="left"><font size="2" face="serif"><br>May 3, 2006</font></td>
</tr>
</table>
<p align="center"><font face="serif" size="2">4</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p><a href="#contents"><font size="2">Back to Contents</font></a></p>
<p align="center"><font size="2" face="serif"><b>EXHIBIT INDEX</b></font></p>
<p align="center"><font size="2" face="serif"><b>(Pursuant to Item 601 of Regulation S-K)</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><font size="2" face="serif"><b><u>Exhibit No.</u></b></font></td>
<td align="left" width="2%">&nbsp;</td>
<td width="1%" align="right">&nbsp;</td>
<td width="40%" align="left"><font size="2" face="serif"><b><u>Exhibit</u></b></font></td>
<td width="2%" align="left">&nbsp;</td>
<td width="1%" align="right">&nbsp;</td>
<td width="30%" align="left"><font size="2" face="serif"><b><u>Reference</u></b></font></td>
<td width="2%" align="left">&nbsp;</td> </tr>
<tr valign="top">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr valign="top" bgcolor="#ffffff">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="left"><font size="2" face="serif">5</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Opinion of Duane Morris LLP</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Filed herewith</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><font size="2" face="serif">23.1</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Consent of Duane Morris LLP (included in its opinion filed as Exhibit 5)</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Filed herewith</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#ffffff">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="left"><font size="2" face="serif">23.2</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Consent of KPMG LLP</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Filed herewith</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="right">&nbsp;</td>
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="left"><font size="2" face="serif">24</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Power of Attorney (see page 3 of this Registration Statement)</font></td>
<td align="left">&nbsp;</td>
<td align="right">&nbsp;</td>
<td align="left"><font size="2" face="serif">Filed herewith</font></td>
<td align="left">&nbsp;</td>
</tr>
</table>
<p align="center"><font face="serif" size="2">5</font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "s-eight.htm", "description": "S-8", "secsgml_size_bytes": 26976}]
{"company-data": {"conformed-name": "ERESEARCHTECHNOLOGY INC /DE/", "cik": "0001026650", "assigned-sic": "8734", "irs-number": "223264604", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-133775", "film-number": "06804847"}, "business-address": {"street1": "30 SOUTH 17TH STREET", "city": "PHILADELPHIA", "state": "PA", "zip": "19103", "phone": "2159720420"}, "mail-address": {"street1": "30 SOUTH 17TH STREET", "city": "PHILADELPHIA", "state": "PA", "zip": "19102"}, "former-company": {"former-conformed-name": "PREMIER RESEARCH WORLDWIDE LTD", "date-changed": "19961107"}}
Prepared and filed by St Ives Financial
As filed with the Securities and Exchange Commission on May 3, 2006
Registration No. 333-_________
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
____________________
FORM S-8
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
____________________
eResearchTechnology, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware
22-3264604
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
30 South 17
th
Street
Philadelphia, Pennsylvania
(Address of Principal Executive Offices)
19103
(Zip Code)
eResearchTechnology, Inc.
2003
Stock Option Plan
(Full title of plan)
______________________
Joel Morganroth, M.D.
Chairman of the Board and
Chief Scientific Officer
eResearchTechnology, Inc.
30 South 17
th
Street
Philadelphia, Pennsylvania  19103
(215)
972-0420
(Name, address and telephone number of agent for service)
____________________
Copy to:
Thomas G. Spencer, Esquire
Duane Morris LLP
30 South 17
th
Street
Philadelphia, Pennsylvania  19103-7396
CALCULATION OF REGISTRATION FEE
Title of securities
to be registered
Amount to be
Registered(1)
Proposed
maximum offering
price per share(2)
Proposed
maximum aggregate
offering price(2)
Amount of
registration fee
Common Stock,
par value $.01
3,500,000 shares
$11.095
$38,832,500
$4,156
(1)
This registration statement registers an additional 3,500,000 shares to be offered and sold under the eResearchTechnology, Inc. 2003 Stock Option Plan (the "Plan").  This registration statement also registers such additional shares as may be required to be issued under the Plan in the event of any future stock dividend, reverse stock split, split-up, reclassification and/or other similar event.
(2)
Pursuant to paragraph (h) of Rule 457, the proposed maximum offering price per share and the proposed maximum aggregate offering price have been computed on the basis of $11.095 per share, the average of the high and low sales prices of the Common Stock of the Company on the Nasdaq National Market System on May 1, 2006, which is a day on which the Common Stock traded that is within five business days prior to the date of filing.
Back to Contents
Introductory statement pursuant
to general instruction E to form s-8
The shares being registered hereunder constitute an additional 3,500,000 shares of Common Stock of eResearchTechnology, Inc. (the "Company") for issuance under the Company's 2003 Stock Option Plan (the "Plan").  On July 23, 2003, the Company registered 1,700,000 shares of Common Stock for offer and sale under the Plan under the Securities Act of 1933 on Registration Statement No. 333-107272 on Form S-8, which registration statement also registered additional shares of Common Stock issuable under the Plan in the event of any future stock dividend, reverse stock split, split-up, declassification and/or other similar event, such that, as a result of stock dividends subsequently declared and
paid by the Company, such registration statement registered a total of 3,818,625 shares as of the date hereof.  Pursuant to General Instruction E to Form S-8, with respect to the registration of additional securities hereunder for issuance under the Plan, the contents of the Company's Registration Statement No. 333-107272 are incorporated herein by reference.
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 3.     Incorporation of Documents by Reference.
The following material is incorporated herein by reference:
(a)     The Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2005 as filed with the Securities and Exchange Commission (the "Commission") on March 10, 2006.
(b)     The Company's Current Reports on Form 8-K as filed with the Commission on January 24, 2006, February 8, 2006 and April 26, 2006.
(c)     The description of the Company's Common Stock set forth in the Company's Registration Statement on Form S-1 filed with the Commission, File No. 333-17001, declared effective by the Commission on February 3, 1997.
All reports or other documents filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 subsequent to the date of this Registration Statement, in each case filed by the Company prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such reports and documents.  Any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for the purposes of this Registration
Statement to the extent that a statement contained herein or in any other subsequently filed document, which also is or is deemed to be incorporated herein by reference, modifies or supersedes such statement.  Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
1
Back to Contents
Item 8.     Exhibits.
4
eResearchTechnology, Inc. 2003 Stock Option Plan (incorporated by reference to Exhibit 10.3 to the Company's Form 10-Q Report for the Fiscal Quarter Ended June 30, 2003, as filed on August 7, 2003).
5
Opinion of Duane Morris LLP.
23.1
Consent of Duane Morris LLP (included in its opinion filed as Exhibit 5).
23.2
Consent of KPMG LLP.
24
Power of Attorney (included on the signature pages hereto).
2
Back to Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Philadelphia, Pennsylvania on May 3, 2006.
eResearchTechnology, Inc.
By:
/s/ Joseph A. Esposito
Joseph A. Esposito
President and Chief Executive Officer
Know all men by these presents, that each person whose signature appears below constitutes and appoints Joel Morganroth, M.D. and Anna Marie Pagliaccetti, and each of them, as such person's true and lawful attorneys-in-fact and agents, with full power of substitution, for such person, and in such person's name, place and stead, in any and all capacities to sign any or all amendments or post-effective amendments to this Registration Statement, and to file same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitutes, may lawfully do or cause to be done by virtue hereof.
3
Back to Contents
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/ Joseph A. Esposito
Joseph A. Esposito
President, Chief Executive
Officer and Director (Principal executive officer)
May 3, 2006
/s/ Joel Morganroth
Joel Morganroth, M.D.
Chairman of the Board and Chief Scientific Officer
May 3, 2006
/s/ Bruce Johnson
Bruce Johnson
Executive Vice President and Chief
    Financial Officer
(Principal financial and accounting officer)
May 3, 2006
/s/ Sheldon M. Bonovitz
Sheldon M. Bonovitz
Director
May 3, 2006
/s/ David D. Gathman
David D. Gathman
Director
May 3, 2006
/s/ Gerald A. Faich
Gerald A. Faich, M.D., M.P.H.
Director
May 3, 2006
/s/ Elam M. Hitchner
Elam M. Hitchner
Director
May 3, 2006
/s/ John H. Park
John H. Park
Director
May 3, 2006
/s/ Stephen S. Phillips
Stephen S. Phillips
Director
May 3, 2006
/s/ Stephen M. Scheppmann
Stephen M. Scheppmann
Director
May 3, 2006
4
Back to Contents
EXHIBIT INDEX
(Pursuant to Item 601 of Regulation S-K)
Exhibit No.
Exhibit
Reference
5
Opinion of Duane Morris LLP
Filed herewith
23.1
Consent of Duane Morris LLP (included in its opinion filed as Exhibit 5)
Filed herewith
23.2
Consent of KPMG LLP
Filed herewith
24
Power of Attorney (see page 3 of this Registration Statement)
Filed herewith
5